TPH1 and neoplasm: Silencing TPH‐1 or 5‐HTR3A, or treatment with the TPH‐1 inhibitor 4‐chloro‐L‐phenylalanine or the 5‐HTR3A antagonist tropisetron, alleviates tumor development [248].